(Q43712734)

26 November 2017

0 references

Licorice for hepatitis C: yum-yum or just ho-hum? (English)

1 reference

26 November 2017

Lewis JH

1

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

The American Journal of Gastroenterology

26 November 2017

published in

1 reference

26 November 2017

volume

96

1 reference

26 November 2017

issue

8

1 reference

26 November 2017

page(s)

2291-2292

1 reference

The long term efficacy of glycyrrhizin in chronic hepatitis C patients.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04029.X

Glycyrrhizic acid in liquorice--evaluation of health hazard

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04029.X

The effect of retreatment with interferon-alpha on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04029.X

New treatment strategies in non-responder patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04029.X

A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04029.X

Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04029.X

The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04029.X

Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double‐blind, randomized, placebo‐controlled phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04029.X

Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2001.04029.X

10.1111/J.1572-0241.2001.04029.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference